NEW YORK (GenomeWeb) – Provista Diagnostics today announced it has expanded a licensing deal for certain biomarkers and autoantibody technologies identified by researchers at the Biodesign Institute of Arizona State University.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.